FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/21/2025
Back to search
Official data from USPTO
PXB-SHIZUKU
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PXB-SHIZUKU
ST13
US500000079378897Class
1, 5
Filing
79378897
Registration
7602251
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/03/2026
Trademark type
Word
Nice classes
1, 5
Filing date
07/25/2023
Registration date
12/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
PhoenixBio Co., Ltd.
Representatives
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; biological preparationsother than for medical or veterinary purposes; cells for scientific and research use; cells for scientific or research useother than for medical or veterinary purposes; cell culture medium for scientific or research useother than for medical or veterinary use; cell culture conditioned medium for scientific or research useother than for medical or veterinary purposes; supernatant of cell culture medium for scientific or research useother than for medical or veterinary purposes; supernatant fluid of cell culture medium for scientific or research useother than for medical or veterinary purposes
Class 5
Pharmaceutical preparations for treatment of diabetes mellitusliver disease treatmentsurgical treatmentneurological disease treatmentdyslipidemia treatmenttreatment of blood coagulation disorderstreatment of metabolic disorders of iron and coppertreatment of congenital metabolic disorderstreatment of trace element deficiencytreatment of infectious diseases for use in regenerative medicine; medicines for treatment of diabetes mellitusliver disease treatmentsurgical treatmentneurological disease treatmentdyslipidemia treatmenttreatment of blood coagulation disorderstreatment of metabolic disorders of iron and coppertreatment of congenital metabolic disorderstreatment of trace element deficiencytreatment of infectious diseases for use in regenerative medicine for human purposes; medicines for treatment of diabetes mellitusliver disease treatmentsurgical treatmentneurological disease treatmentdyslipidemia treatmenttreatment of blood coagulation disorderstreatment of metabolic disorders of iron and coppertreatment of congenital metabolic disorderstreatment of trace element deficiencytreatment of infectious diseases for use in regenerative medicine for veterinary purposes; cells for medical or veterinary purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; cell culture medium for medical and veterinary purposes; cell culture conditioned medium for medical and veterinary purposes; supernatant of cell culture medium for medical and veterinary purposes; supernatant fluid of cell culture medium for medical and veterinary purposes
Publications
History of USPTO decisions and trademark events.
38 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/28/2025
FIMP
FINAL DISPOSITION PROCESSED
05/28/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/25/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/17/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/01/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/12/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2024
PUBO
PUBLISHED FOR OPPOSITION
10/15/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/19/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/19/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/19/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/29/2024
GNFR
FINAL REFUSAL E-MAILED
05/29/2024
CNFR
FINAL REFUSAL WRITTEN
05/29/2024
RFNT
REFUSAL PROCESSED BY IB
05/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/29/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/29/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/29/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/29/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/29/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/29/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/29/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/29/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/29/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/17/2024
RFRR
REFUSAL PROCESSED BY MPU
04/16/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/28/2024
CNRT
NON-FINAL ACTION WRITTEN
03/27/2024
DOCK
ASSIGNED TO EXAMINER
03/27/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/19/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/14/2023
Continuous trademark protection
Get notified about every new filing that threatens PXB-SHIZUKU or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.